SI
SI
discoversearch

Biotech / Medical
Sorrento Therapeutics Inc
An SI Board Since January 2010
Posts SubjectMarks Bans Symbol
90 8 0 SRNE
Emcee:  alenor Type:  Unmoderated
Remember QBSW? Quikbyte did a reverse merger and is now:
"Sorrento Therapeutics, Inc. is a development-stage biopharmaceutical company focused on applying its proprietary technology platform for the discovery and development of human therapeutic antibodies for the treatment of a variety of disease conditions, including cancer, inflammation, metabolic disease and infectious disease."
Recent news starts like this:
"SAN DIEGO, Jan 11, 2010 /PRNewswire via COMTEX News Network/ --
Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) today announced an antibody discovery and development collaboration with The Scripps Research Institute, La Jolla, CA. Under the terms of the agreement, Sorrento Therapeutics obtains an exclusive, worldwide license to the Institute's novel technology, based on quorum sensing, for the prevention and treatment of Staphylococcus aureus ('Staph') infections, including Methicillin-resistant Staph. aureus (MRSA). ..."
***** MOST RECENT *****
SAN DIEGO, Aug. 1, 2013 /PRNewswire via COMTEX/ -- Sorrento Therapeutics, Inc. (OTCQB: SRNE; Sorrento) announced today that it has filed a Certificate of Amendment to its Restated Certificate of Incorporation to effect a 1-for-25 reverse stock split of its common stock, effective on July 30, 2013. The proposal to effect a reverse stock split was approved by the Company`s stockholders at its Special Meeting of Stockholders held on April 26, 2013, and the specific 1-for-25 ratio was subsequently approved by the Company`s Board of Directors. At the effective time of the reverse stock split, every twenty five shares of the Company`s issued and outstanding common stock will be automatically converted into one issued and outstanding share of common stock, without any change in par value per share. The reverse stock split will affect all shares of the Company`s common stock outstanding immediately prior to the effective time of the reverse stock split, as well as the number of shares of common stock available for issuance under the Company`s equity incentive plans. In addition, the reverse stock split will effect a reduction in the number of shares of common stock issuable upon the exercise of stock options or warrants outstanding immediately prior to the effectiveness of the reverse stock split. No fractional shares will be issued as a result of the reverse stock split. The Company`s common stock will begin trading on the OTC QB on a split-adjusted basis when the market opens on Thursday, August 1, 2013. The new CUSIP number for the Company`s common stock following the reverse stock split is 83587F 202.

Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
90Sorrento Therapeutics issues Chairman/CEO corporate update to stockholders finaJulius Wong-June 15
89 Hong Kong market could open cash flood gates for U.S. biotechs finance.yahoo.cJulius Wong-June 14
88 Sorrento Therapeutics, Inc. [graphic]Julius Wong-May 24
87 Sorrento Therapeutics Receives a Buy from Oppenheimer analystratings.comJulius Wong-March 20
86 FDA approves Sorrento's non-opioid painkiller patch, shares jump finance.yJulius Wong-March 1
85celgene-spinout-celularity-raises-250-million-to-develop-placental-cells-to-attaJulius Wong-February 20
84 Sorrento Therapeutics, Inc. Chairman/CEO letter to stockholders finance.yahoo.Julius Wong-February 5
83The RSI is rising and in the bullish zone with the MACD also moving higher. On wAlejandroo Green-January 17
82 Sorrento: Undervalued Biotech with a Potential Blockbuster CAR T Therapy youtuJulius Wong-January 12
81 Sorrento Therapeutics, Inc. [graphic]Julius Wong-10/12/2017
80FDA accepts Sorrento's resubmitted marketing application for ZTlido, action Julius Wong-9/12/2017
79FDA OKs Sorrento's IND for non-opioid pain candidate resiniferatoxin, clinicJulius Wong-6/29/2017
78 Sorrento Therapeutics' Pain Subsidiary, SCILEX Pharmaceuticals, Announces PJulius Wong-6/14/2017
77 Form 8-K stocknewsflow.comJulius Wong-6/14/2017
76Getting ready for the bounce back up. [graphic]hollyhunter-5/23/2017
75 Major owner of Sorrento Therapeutics, Inc. just declared owning 8,132,536 shareJulius Wong-4/27/2017
74Sorrento Therapeutics up 9% as CEO adds to stake CEO Henry Ji took down 100K shaJulius Wong-4/19/2017
73 Major owner of Sorrento Therapeutics, Inc. just picked up 2,500,000 shares coJulius Wong-4/17/2017
72Appreciate the linksjonsol-4/15/2017
71I don't have good knowledge about the company. ****** From blog.thevcf.coJulius Wong-4/15/2017
70Any thoughts on the recent offering; clues on why, where it might head?jonsol-4/15/2017
69Sorrento readies equity offering; shares sink 27% after hours Sorrento TherapeutJulius Wong-4/12/2017
68SRNE Form 10-K biz.yahoo.comJulius Wong-3/22/2017
67 Insider buying Feb 03, at $5.15 elite.finviz.comJulius Wong-2/3/2017
66 Form 8-K for SORRENTO THERAPEUTICS, INC. In consideration for the rights granJulius Wong-7/11/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.